Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model

Figure 4

Immunofluorescent (IF) staining for Ki-67+ cells and TRPC1+ cells in medial layer of large pulmonary arterioles (PA) by day 28 after pulmonary arterial hypertension (PAH) (). ((a) to (c)) Identification of Ki-67+ cells in PA (white arrow) with IF double staining (i.e., α-SMA-Ki-67) in three groups of animals (400x). (d) versus other groups with different symbols (, †, ‡), . ((e) to (g)) Identification of TRPC1+ cells in PA (white arrow) using IF double staining (i.e., α-SMA-γ-TRPC1) in the three groups (400x). (h) versus other groups with different symbols (, †, ‡), . The scale bars in right lower corner represent 20 μm. Blue fluorescence indicates DAPI-stained nuclei. Statistical analysis in (d) and (h) using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (, †, ‡) indicate significance (at 0.05 level).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)